Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06620341
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-27
Brief Title:
A Cluster Randomized Controlled Trial to Compare the Rate of Antibiotic Infusion
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparing the Rate of Antibiotic Infusion Among Patients with Acute Upper Respiratory Tract Bacterial Infections in the Emergency Department -- a Cluster Randomized Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Acute upper respiratory tract infection commonly known as upper respiratory infection is an acute inflammation primarily affecting the nose pharynx or larynx caused by various viruses andor bacteria Viruses are more common accounting for 70 to 80 of cases while bacterial infections account for 20 to 30 For a long time the high rate of intravenous infusion use has been a prominent issue in clinical diagnosis and treatment in China The irrational and excessive use of antimicrobials in emergency patients with upper respiratory tract bacterial infections has also become increasingly apparent imposing unnecessary financial burdens and risks of drug side effects on patients Therefore reducing the rate of intravenous antimicrobial administration in emergency patients with upper respiratory tract bacterial infections has become an urgent problem to be solved By implementing measures such as health education by clinical pharmacists and enhancing the awareness of rational antimicrobial use in doctors it is expected to lower the rate of intravenous antimicrobial administration reduce the occurrence of drug resistance improve treatment convenience for patients and lower treatment costs while ensuring therapeutic efficacy
The purpose of this study was to investigate whether clinical pharmacists can reduce the intravenous infusion rate of antimicrobials in emergency patients with upper respiratory tract bacterial infections through medication education for emergency medical staff and to observe whether this intervention will affect the prognosis and medication safety of these patients
The purpose of this study was to investigate whether clinical pharmacists can reduce the intravenous infusion rate of antimicrobials in emergency patients with upper respiratory tract bacterial infections through medication education for emergency medical staff and to observe whether this intervention will affect the prognosis and medication safety of these patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None